Teva Pharmaceutical Industries Ltd (TEVA)
16.26
+0.26
(+1.59%)
USD |
NYSE |
May 10, 16:00
16.28
+0.02
(+0.15%)
After-Hours: 20:00
Teva Pharmaceutical Industries Cash from Operations (TTM): 1.389B for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.389B |
December 31, 2023 | 1.368B |
September 30, 2023 | 1.157B |
June 30, 2023 | 1.695B |
March 31, 2023 | 1.494B |
December 31, 2022 | 1.59B |
September 30, 2022 | 1.073B |
June 30, 2022 | 1.059B |
March 31, 2022 | 1.154B |
December 31, 2021 | 798.00M |
September 30, 2021 | 673.00M |
June 30, 2021 | 451.00M |
March 31, 2021 | 506.00M |
December 31, 2020 | 1.216B |
September 30, 2020 | 1.423B |
June 30, 2020 | 1.441B |
March 31, 2020 | 941.00M |
December 31, 2019 | 748.00M |
September 30, 2019 | 577.00M |
June 30, 2019 | 673.00M |
March 31, 2019 | 1.062B |
December 31, 2018 | 2.446B |
September 30, 2018 | 2.938B |
June 30, 2018 | 3.312B |
March 31, 2018 | 3.585B |
Date | Value |
---|---|
December 31, 2017 | 2.225B |
September 30, 2017 | 1.456B |
June 30, 2017 | 2.122B |
March 31, 2017 | 2.65B |
December 31, 2016 | 3.89B |
September 30, 2016 | 5.415B |
June 30, 2016 | 5.047B |
March 31, 2016 | 5.564B |
December 31, 2015 | 5.542B |
September 30, 2015 | 5.679B |
June 30, 2015 | 6.01B |
March 31, 2015 | 5.583B |
December 31, 2014 | 5.127B |
September 30, 2014 | 4.191B |
June 30, 2014 | 3.211B |
March 31, 2014 | 3.033B |
December 31, 2013 | 3.237B |
September 30, 2013 | 3.998B |
June 30, 2013 | 4.602B |
March 31, 2013 | 4.918B |
December 31, 2012 | 4.572B |
September 30, 2012 | 4.423B |
June 30, 2012 | 3.857B |
March 31, 2012 | 3.99B |
December 31, 2011 | 4.134B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
451.00M
Minimum
Jun 2021
1.695B
Maximum
Jun 2023
1.071B
Average
1.114B
Median
Cash from Operations (TTM) Benchmarks
Viatris Inc | 2.800B |
Alvotech | -312.18M |
AstraZeneca PLC | 9.698B |
Corcept Therapeutics Inc | 124.84M |
GSK PLC | 9.572B |